Eyepoint Pharmaceuticals, Inc. (EYPT)

Last Three Months

11-Feb-24 -- 10-May-24

Time Period:

Three Months
|
Year

$10.08M Net Amount

Buy:	$10.08M	$11.86
Sell:	0	--

Company Sentiment

Scientific & Technical Instruments

Electronics

Insider Trading Sentiment: Strong Buy

Insider Trading Sentiment: Strong Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

23

0

1

+1

0

+2

1

+3

Two Year Chart

11-May-22 -- 10-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
02-Apr-24 5:27 PM View:	30-Mar-24 Payment of Exercise ($528.04K)	Paggiarino Dario A. Chief Medical Officer		Eyepoint Pharmaceuticals, Inc. - EYPT	59% 42.22K to 67.08K	0	0	--	--	Show Txns Hide Txns

13-Feb-24 5:40 PM View:	13-Feb-24 Gift 0	Lurker Nancy Executive Vice Chair Director		Eyepoint Pharmaceuticals, Inc. - EYPT	0% 210.24K	0	0	--	--	Show Txns Hide Txns

28-Feb-24 4:46 PM View:	27-Feb-24 Gift 0	Duker Jay S. President and CEO Director		Eyepoint Pharmaceuticals, Inc. - EYPT	0% 51.92K	0	0	--	--	Show Txns Hide Txns

08-May-24 4:23 PM View:	06-May-24 Market Purchase $10.08M	Cormorant Asset Management,... 10% Owner		Eyepoint Pharmaceuticals, Inc. - EYPT	21% 6.89M to 8.32M	$10.08M 12%	0	$11.86	--	Show Txns Hide Txns